Loading...
Clinical and Transcriptional Response to the Long-Acting Interleukin-1 Blocker Canakinumab in Blau Syndrome-Related Uveitis
OBJECTIVE: To report on the clinical response to canakinumab in a patient with sporadic nucleotide-binding oligomerization domain–containing protein 2 (NOD-2)–associated pediatric granulomatous arthritis (Blau syndrome) and severe resistant panuveitis, and to describe gene expression profile changes...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3684148/ https://ncbi.nlm.nih.gov/pubmed/23124805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.37776 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|